Fever-Tree bets on U.S. to get growth fizzing again
Proper news from Britain - News from Britain you won’t find anywhere else. Not the tosh the big media force-feed you every day!
Fever-Tree's international expansion will be in the spotlight when it updates investors this week.
The firm, which makes tonic water and other mixers, has been focused on cracking the US market after a slump in UK sales growth.
Shares fizzed when Fever-Tree earlier this year announced that Molson Coors had bought an 8.5 per cent stake in the business for £71m.
The tie-up with the US brewer is part of a plan to drive further growth in America – which has become the Aim-listed firm's largest market.
But analysts expect Fever-Tree to reiterate its low single digit sales growth guidance for the full year in a trading update on Thursday.
The Molson Coors partnership 'is expected to help drive the next leg of growth in North America,' Hargreaves Lansdown analyst Aarin Chiekrie said.
DIY INVESTING PLATFORMS
Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.
Compare the best investing account for you
